Development and preclinical evaluation of Terbium-based radiopharmaceuticals for imaging and treatment of cancer KU Leuven
Cancer is one of the most frequently diagnosed diseases in the western world. Terbium has gather interest over the last decade as there are 4 radioisotopes which can be used in the medicinal space. Of these, 161Tb has become an interesting prospect for the radiopharmaceutical world, as it has both a therapeutic ß- decay (ave. energy = 0.15 MeV) and a diagnostic gamma (ave. energy = 49 keV). The therapeutic potential is greatly enhanced by ...